If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEkf Diagnostics Regulatory News (EKF)

Share Price Information for Ekf Diagnostics (EKF)

Share Price is delayed by 15 minutes
Get Live Data
26.30    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.60 (2.344%)
Market Cap: £113.16m
EKF Live PriceLast checked at - London Stock Exchange

Intraday Ekf Diagnostics Share Chart

Appointment of a Director

21 Dec 2015 07:00

RNS Number : 6546J
EKF Diagnostics Holdings PLC
21 December 2015
 

 

21 December 2015

EKF Diagnostics Holdings plc("EKF" or the "Company")

 

Directorate Change

 

EKF Diagnostics Holdings plc (AIM: EKF) is pleased to announce that Lurene Joseph joins the Board as a non-executive director with immediate effect.

 

Lurene has held Chief Executive positions at Leeds and Partners Limited and the London Development Agency, a strategic organisation responsible for jobs, skills and economic growth in London. At both organisations, Lurene was instrumental in bringing about transformational change and driving value with a focus on delivery. Prior to joining the London Development Agency, Lurene was a member of the management team at Royal Dutch Shell Plc and a Vice President at TXU Energy Retail Company LLC.

 

Disclosures in accordance with the AIM Rules for Lurene Julia Wong Joseph, aged 55:

Current DirectorshipsMaraval Limited

Past Directorships in the previous five yearsLeeds and Partners LimitedLondon Development AgencyWomen’s Pioneer HousingRoyal Docks Management AuthoritySME Wholesale Finance Limited

Lurene was a director of Leeds and Partners Limited which was put into voluntary liquidation on 31 March 2015 as part of a strategic move to a wider regional inward investment agenda.

There are no further disclosures required in accordance with AIM Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies.

 

EKF Diagnostics Holdings plc

Tel: 029 2071 0570

Ron Zwanziger, Non-Executive Chairman

Tel: +1 339 221 6282

Julian Baines, CEO

Mob: 07788 420 859

 

 

Panmure Gordon (UK) Limited

Tel: 020 7886 2500

Robert Naylor (Corporate Finance)

Paul Fincham (Corporate Finance)

 

 

Walbrook PR Limited 

Tel: 020 7933 8780 or ekf@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07584 391 303

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABBLFLELFBFBQ
Date   Source Headline
15th Jun 202612:36 pmRNSShare Buyback
12th Jun 20267:00 amRNSShare Buyback
11th Jun 20267:00 amRNSShare Buyback
20th May 20265:41 pmRNSLong Term Incentive Plan Award
19th May 202612:24 pmRNSResult of AGM
19th May 20267:00 amRNSAGM statement & positive Q1 trading update
27th Apr 20267:00 amRNSBoard Changes
24th Apr 20264:43 pmRNSPosting of Annual Report & Notice of AGM
13th Apr 20267:00 amRNSAcquisition of assets from Beep Insights
10th Apr 20269:12 amRNSShare Buyback
8th Apr 20262:33 pmRNSShare Buyback
7th Apr 20261:09 pmRNSShare Buyback
2nd Apr 20267:00 amRNSShare Buyback
31st Mar 20265:59 pmRNSShare Buyback
24th Mar 20267:00 amRNSFull year results
20th Mar 202611:25 amRNSShare Buyback
19th Mar 202611:20 amRNSShare Buyback
19th Mar 20267:00 amRNSHolding(s) in Company
18th Mar 20269:58 amRNSShare Buyback
6th Mar 20267:00 amRNSShare Buyback
5th Mar 20267:00 amRNSNotice of Results
3rd Mar 20267:00 amRNSThree-year Hematology purchasing agreement
2nd Mar 20263:30 pmRNSTotal Voting Rights
27th Feb 20267:00 amRNSShare Buyback
19th Feb 20267:00 amRNSShare Buyback Programme
2nd Feb 20267:00 amRNSShare Buyback & Completion of Buyback Programme
30th Jan 20267:00 amRNSShare Buyback
29th Jan 20267:00 amRNSShare Buyback
28th Jan 202611:41 amRNSShare Buyback
27th Jan 20267:00 amRNSFY 2025 Trading Update
15th Jan 20267:00 amRNSShare Buyback
14th Jan 202611:43 amRNSShare Buyback
14th Jan 20269:37 amRNSShare Buyback
12th Jan 20269:45 amRNSShare Buyback
9th Jan 20265:00 pmRNSShare Buyback
8th Jan 20269:40 amRNSShare Buyback
6th Jan 20266:03 pmRNSShare Buyback
2nd Jan 202610:23 amRNSShare Buyback
31st Dec 202510:45 amRNSShare Buyback
31st Dec 202510:45 amRNSShare Buyback
30th Dec 20257:00 amRNSShare Buyback
30th Dec 20257:00 amRNSShare Buyback
29th Dec 20257:00 amRNSShare Buyback
29th Dec 20257:00 amRNSShare Buyback
24th Dec 202510:43 amRNSShare Buyback
24th Dec 202510:43 amRNSShare Buyback
23rd Dec 20255:23 pmRNSShare Buyback
23rd Dec 20255:23 pmRNSShare Buyback
22nd Dec 202511:10 amRNSShare Buyback
22nd Dec 202511:10 amRNSShare Buyback

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.